TransMedics grants stock options and RSUs to nine new employees as hiring incentives.

TransMedics Group, a medical technology company specializing in organ transplant therapy, granted stock options for 71,815 shares and 47,924 restricted stock units (RSUs) to nine new employees on October 28, 2026. These grants, including significant awards to CFO Fernando Araujo, serve as inducements for joining the company. The stock options have a 10-year term with a $66.90 exercise price, vesting over four years, aligning employee incentives with company performance. This move supports TransMedics' growth strategy in advancing organ transplant technologies.

As of Oct 31, 2026 03:21 WIB, TransMedics Group Inc (TMDX) trades at USD 66.00 on Pluang, down 1.67% in the last day. The stock sees a typical hold time of 26 days among investors, with a market cap of $2.33 billion and a high sell order activity of 86%. This trading activity highlights investor caution shortly after the company granted inducement stock options to new employees.